{"id":"https://openalex.org/W2006556752","doi":"https://doi.org/10.1097/adm.0b013e31809b5df2","title":"Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice Setting","display_name":"Two-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice Setting","publication_year":2007,"publication_date":"2007-06-01","ids":{"openalex":"https://openalex.org/W2006556752","doi":"https://doi.org/10.1097/adm.0b013e31809b5df2","mag":"2006556752","pmid":"https://pubmed.ncbi.nlm.nih.gov/21768942"},"language":"en","primary_location":{"id":"doi:10.1097/adm.0b013e31809b5df2","doi":"https://doi.org/10.1097/adm.0b013e31809b5df2","is_oa":false,"landing_page_url":"https://doi.org/10.1097/adm.0b013e31809b5df2","pdf_url":null,"source":{"id":"https://openalex.org/S107832660","display_name":"Journal of Addiction Medicine","issn_l":"1932-0620","issn":["1932-0620","1935-3227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addiction Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084350787","display_name":"James W. Finch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"James W. Finch","raw_affiliation_strings":["From BioPsych Consulting, Califon, NJ","BioPsych Consulting, Califon, NJ","reprint requests to Dr. James W. Finch, 910 Broad Street, Durham, NC 27705. e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From BioPsych Consulting, Califon, NJ","institution_ids":[]},{"raw_affiliation_string":"BioPsych Consulting, Califon, NJ","institution_ids":[]},{"raw_affiliation_string":"reprint requests to Dr. James W. Finch, 910 Broad Street, Durham, NC 27705. e-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021180601","display_name":"Jonathan B. Kamien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan B. Kamien","raw_affiliation_strings":["BioPsych Consulting, Califon, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioPsych Consulting, Califon, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080366556","display_name":"Leslie Amass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leslie Amass","raw_affiliation_strings":["BioPsych Consulting, Califon, NJ","Leslie Amass is currently employed by Schering-Plough Corporation, a distributor of buprenorphine worldwide, excluding the United States, Australia, and New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioPsych Consulting, Califon, NJ","institution_ids":[]},{"raw_affiliation_string":"Leslie Amass is currently employed by Schering-Plough Corporation, a distributor of buprenorphine worldwide, excluding the United States, Australia, and New Zealand","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5084350787"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7523,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.89198645,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"1","issue":"2","first_page":"104","last_page":"110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine-naloxone","display_name":"buprenorphine/naloxone","score":0.996999979019165},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9399999976158142},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/office-based-opioid-treatment","display_name":"office-based opioid treatment","score":0.7210000157356262},{"id":"https://openalex.org/keywords/private-practice","display_name":"private practice","score":0.6819999814033508},{"id":"https://openalex.org/keywords/heroin-use","display_name":"heroin use","score":0.7179999947547913},{"id":"https://openalex.org/keywords/people-who-inject-drugs","display_name":"people who inject drugs","score":0.8420000076293945},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.6669999957084656},{"id":"https://openalex.org/keywords/urine-drug-testing","display_name":"urine drug testing","score":0.6349999904632568},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.32199999690055847},{"id":"https://openalex.org/keywords/physician-experience","display_name":"physician experience","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8348819017410278},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8281111717224121},{"id":"https://openalex.org/C2776029756","wikidata":"https://www.wikidata.org/wiki/Q407535","display_name":"Oxycodone","level":4,"score":0.574602484703064},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5604133605957031},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.5575653314590454},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.5536466836929321},{"id":"https://openalex.org/C2779225474","wikidata":"https://www.wikidata.org/wiki/Q842424","display_name":"Urinalysis","level":3,"score":0.5534383654594421},{"id":"https://openalex.org/C2778903061","wikidata":"https://www.wikidata.org/wiki/Q17156814","display_name":"Methadone maintenance","level":3,"score":0.5327109694480896},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5306270122528076},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.4984750747680664},{"id":"https://openalex.org/C2909451232","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opiate Substitution Treatment","level":5,"score":0.48753640055656433},{"id":"https://openalex.org/C2779158186","wikidata":"https://www.wikidata.org/wiki/Q303646","display_name":"Hydromorphone","level":4,"score":0.4330989718437195},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.431530624628067},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3088679611682892},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.26715195178985596},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23503363132476807},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.2141624391078949},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.10524958372116089},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/adm.0b013e31809b5df2","doi":"https://doi.org/10.1097/adm.0b013e31809b5df2","is_oa":false,"landing_page_url":"https://doi.org/10.1097/adm.0b013e31809b5df2","pdf_url":null,"source":{"id":"https://openalex.org/S107832660","display_name":"Journal of Addiction Medicine","issn_l":"1932-0620","issn":["1932-0620","1935-3227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addiction Medicine","raw_type":"journal-article"},{"id":"pmid:21768942","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21768942","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of addiction medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W95949195","https://openalex.org/W383399767","https://openalex.org/W1964032526","https://openalex.org/W1969191499","https://openalex.org/W1970347370","https://openalex.org/W1977681341","https://openalex.org/W2005725662","https://openalex.org/W2011162668","https://openalex.org/W2014523709","https://openalex.org/W2018017357","https://openalex.org/W2027873427","https://openalex.org/W2046457014","https://openalex.org/W2061007797","https://openalex.org/W2071956502","https://openalex.org/W2078504997","https://openalex.org/W2097042779","https://openalex.org/W2099536555","https://openalex.org/W2101372918","https://openalex.org/W2121538801","https://openalex.org/W2145139215","https://openalex.org/W2147528480","https://openalex.org/W2148488822","https://openalex.org/W2150622631","https://openalex.org/W2155057413","https://openalex.org/W2172169298","https://openalex.org/W2334237091","https://openalex.org/W4240267522"],"related_works":["https://openalex.org/W2124234312","https://openalex.org/W1975499887","https://openalex.org/W2468821862","https://openalex.org/W2012069003","https://openalex.org/W82755264","https://openalex.org/W4245917018","https://openalex.org/W2338583002","https://openalex.org/W7099802979","https://openalex.org/W2042825630","https://openalex.org/W2134732195"],"abstract_inverted_index":{"Office-based":[0],"buprenorphine-naloxone":[1],"(Suboxone)":[2],"treatment":[3,156,177,189,234],"in":[4,25,53,175],"the":[5,222,225],"United":[6],"States":[7],"has":[8],"significantly":[9,237],"improved":[10],"access":[11],"to":[12,50,183,245],"safe":[13],"and":[14,78,84,98,103,114,221,236,241],"effective":[15],"opioid-dependence":[16],"therapy.":[17,257],"Little":[18],"data":[19],"from":[20],"physicians'":[21],"experiences":[22],"prescribing":[23,45],"Suboxone":[24,46,64,136,155,176,216,228],"private":[26,55],"offices":[27],"have":[28],"been":[29],"available.":[30],"This":[31],"retrospective":[32],"chart":[33],"review":[34],"describes":[35],"a":[36,54,164],"family":[37],"practitioner's":[38],"first":[39],"2":[40],"years":[41,91,94],"of":[42,71,95,149,254],"clinical":[43],"experience":[44,226],"for":[47,82,126,166],"opioid":[48,96,239],"dependence":[49],"71":[51],"patients":[52,79],"office.":[56],"After":[57],"directly":[58],"observed":[59],"rapid":[60],"office":[61],"dose":[62,132],"induction,":[63],"prescriptions":[65],"were":[66,80,99,152,205],"given":[67],"monthly":[68],"after":[69,154],"evidence":[70],"continued":[72],"stability.":[73],"Urine":[74],"was":[75,134,218,230],"screened":[76],"regularly":[77],"referred":[81],"counseling":[83],"other":[85],"ancillary":[86],"services.":[87],"Patients":[88],"averaged":[89,139],"32":[90],"old,":[92],"4.3":[93],"dependence,":[97],"primarily":[100,110],"white":[101],"(93%)":[102],"employed":[104],"(70%).":[105],"Fifty-two":[106],"percent":[107,169,192],"used":[108],"heroin":[109],"(most":[111],"by":[112,173],"injection),":[113],"70%":[115],"had":[116,170],"no":[117,206],"agonist":[118,255],"substitution":[119,256],"therapy":[120,217],"history.":[121],"Almost":[122,196],"half":[123],"(47%)":[124],"paid":[125,199],"their":[127,200],"own":[128],"treatment.":[129],"Compliance":[130],"during":[131],"induction":[133],"excellent.":[135,227],"maintenance":[137,185,229],"doses":[138],"10":[140],"(range,":[141],"2-24)":[142],"mg":[143],"per":[144],"day.":[145],"More":[146],"than":[147],"80%":[148],"urine":[150],"samples":[151],"opioid-negative":[153],"began,":[157],"although":[158],"urinalysis":[159],"did":[160],"not":[161],"always":[162],"include":[163],"test":[165],"oxycodone.":[167],"Seventy-five":[168],"successful":[171],"outcomes":[172],"remaining":[174],"(43%),":[178],"tapering":[179],"successfully":[180],"(21%),":[181],"transferring":[182],"methadone":[184],"(7%),":[186],"or":[187,210],"inpatient":[188],"(4%).":[190],"Fifty-eight":[191],"reported":[193],"receiving":[194],"counseling.":[195],"all":[197],"(85%)":[198],"fees":[201],"on":[202],"time.":[203],"There":[204],"safety,":[207],"medication":[208],"abuse,":[209],"diversion":[211],"issues":[212],"detected.":[213],"Overall,":[214],"office-based":[215],"easily":[219],"implemented":[220],"physician":[223],"considered":[224],"associated":[231],"with":[232],"good":[233],"retention":[235],"reduced":[238],"use,":[240],"it":[242],"is":[243],"helping":[244],"reach":[246],"patients,":[247],"including":[248],"injection":[249],"drug":[250],"users,":[251],"without":[252],"histories":[253]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}